Medical Device / MedTech

FDA Clears Wellvii’s Portable BP Go Finger Cuff

Medical Product Outsourcing reports FDA clearance for Wellvii’s portable BP Go blood pressure monitoring technology.

By ROOK Industry News
Wellvii BP Go portable finger-based blood pressure monitoring technology

Wellvii Inc.’s BP Go blood pressure monitoring technology has received FDA clearance, according to Medical Product Outsourcing. The publication describes BP Go as a portable blood pressure monitoring technology that uses a finger-based measurement approach.

The reported clearance is a regulatory update for Wellvii and its BP Go technology. Medical Product Outsourcing identifies the product’s core characteristics as portability, blood pressure monitoring and a measurement method based on the finger.

FDA clearance reported for BP Go

Medical Product Outsourcing reported that the FDA cleared Wellvii’s BP Go. The report names Wellvii Inc. as the company behind the blood pressure monitoring technology and identifies FDA clearance as the regulatory event.

BP Go is described in the report as portable. The publication also states that the technology uses a finger-based measurement approach, distinguishing the reported format and method within the blood pressure monitoring category.

Key details for medical-device sales professionals

For professionals following medical-device regulatory developments, the announcement provides a concise set of product details supplied by Medical Product Outsourcing. The update concerns blood pressure monitoring technology rather than a broader company announcement.

  • Company: Wellvii Inc.
  • Technology: BP Go blood pressure monitoring technology
  • Regulatory event: FDA clearance
  • Reported format: Portable
  • Reported measurement approach: Finger-based

Medical Product Outsourcing’s coverage centers on the FDA clearance and the technology’s stated finger-based approach. The report also characterizes BP Go as a portable option for blood pressure monitoring.

What the report establishes

The available report establishes that BP Go achieved FDA clearance and that Wellvii’s technology is intended for blood pressure monitoring. It further identifies a portable design and finger-based measurement approach as the product details highlighted in the announcement.

Medical-device sales professionals tracking blood pressure monitoring developments can reference the regulatory milestone, the company name, and the product characteristics reported by Medical Product Outsourcing when discussing this update.

Sources